Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract
- PMID: 13678233
- DOI: 10.1078/094471103322331449
Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract
Abstract
Green tea extract (EFLA85942) is able to induce specifically the neutral endopeptidase (NEP) activity and to inhibit the proliferation of SK-N-SH cells; the angiotensin-converting enzyme (ACE) activity is not influenced under the same conditions. The treatment of the cells with arabinosylcytosine and green tea extract results in a strong enhancement of cellular NEP activity whereas cellular ACE activity was not changed significantly, indicating a green tea extract-specific regulation of NEP expression. Because of its role in the degradation of amyloid beta peptides this enzyme induction of NEP by long term treatment with green tea extract may have a beneficial effect regarding the prevention of forming amyloid plaques.
Similar articles
-
Induction of neutral endopeptidase and angiotensin-converting enzyme activity of SK-N-SH cells in vitro by quercetin and resveratrol.Pharmazie. 2002 Aug;57(8):556-8. Pharmazie. 2002. PMID: 12227197
-
Induction of neutral endopeptidase (NEP) activity of SK-N-SH cells by natural compounds from green tea.J Pharm Pharmacol. 2006 Apr;58(4):495-501. doi: 10.1211/jpp.58.4.0009. J Pharm Pharmacol. 2006. PMID: 16597367
-
Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B.Phytomedicine. 2006 Mar;13(4):284-9. doi: 10.1016/j.phymed.2004.08.002. Epub 2005 Jun 27. Phytomedicine. 2006. PMID: 16492533
-
Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.Peptides. 2004 Mar;25(3):521-5. doi: 10.1016/j.peptides.2003.12.010. Peptides. 2004. PMID: 15134871 Review.
-
New cancer treatment strategy using combination of green tea catechins and anticancer drugs.Cancer Sci. 2011 Feb;102(2):317-23. doi: 10.1111/j.1349-7006.2010.01805.x. Epub 2010 Dec 30. Cancer Sci. 2011. PMID: 21199169 Review.
Cited by
-
The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?Int J Alzheimers Dis. 2012;2012:383796. doi: 10.1155/2012/383796. Epub 2012 Jul 26. Int J Alzheimers Dis. 2012. PMID: 22900228 Free PMC article.
-
Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration.Front Neurosci. 2018 Nov 19;12:825. doi: 10.3389/fnins.2018.00825. eCollection 2018. Front Neurosci. 2018. PMID: 30510498 Free PMC article. Review.
-
Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.Front Aging Neurosci. 2014 Sep 17;6:235. doi: 10.3389/fnagi.2014.00235. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25278875 Free PMC article. Review.
-
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.Br J Pharmacol. 2019 Sep;176(18):3447-3463. doi: 10.1111/bph.14593. Epub 2019 Mar 11. Br J Pharmacol. 2019. PMID: 30710367 Free PMC article. Review.
-
Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's Disease.Front Aging Neurosci. 2013 Dec 23;5:98. doi: 10.3389/fnagi.2013.00098. Front Aging Neurosci. 2013. PMID: 24391587 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous